Jon Aumais

Company: Genentech

Job title: Formerly Senior Patent Agent

Seminars:

Presentation: Drafting Patent Strategies for Genetically Modified vs. Unmodified Cell Therapies 9:15 am

Compare how patent strategies differ for genetically modified versus unmodified allogeneic cell therapies under U.S. law Explore key challenges in claiming unmodified cells, including novelty, inventiveness, and eligibility Learn practical drafting approaches to protect compositions, methods, and therapeutic use across both therapy typesRead more

day: Day Two